Contribution of myeloperoxidase to coronary artery vasculitis associated with MPO-ANCA production

被引:24
作者
Ishida-Okawara, A
Oharaseki, T
Takahashi, K
Hashimoto, Y
Aratani, Y
Koyama, H
Maeda, N
Naoe, S
Suzuki, K
机构
[1] Natl Inst Infect Dis, Dept Bioact Mol, Shinjuku Ku, Tokyo 1628640, Japan
[2] Toho Univ, Ohashi Hosp, Sch Med, Dept Pathol,Meguro Ku, Tokyo 1538515, Japan
[3] Yokohama City Univ, Kihara Inst Biol Res, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan
[4] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA
关键词
MPO-specific anti-neutrophil cytoplasmic autoantibody production; MPO-deficient mouse; etiology of vasculitis;
D O I
10.1023/A:1012802714421
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The role of myeloperoxidase (MPO) in the pathogenesis of vasculitis associated with MPO-specific anti-neutrophil cytoplasmic autoantibody (MPO-ANCA) was examined in a murine animal model. Coronary artery vasculitis was induced in C57BL/6 mice with and without endogenous MPO by intraperitoneal injection of Candida albicans-derived substances (CADS). The corresponding levels of MPO-ANCA in sera of mice with and without vasculitis were measured and compared in both wild-type and MPO-deficient animals. The MPO-ANCA titers in sera were significantly higher in mice with vasculitis than in vasculitis-negative mice, indicating that MPO-ANCA correlated with vasculitis formation. However, the increase of MPO-ANCA titers observed in sera of wild C57BL/6 mice were strongly suppressed in MPO-deficient C57BL/6 mice, accompanied with prevention of vasculitis formation. These results show that MPO acted as an antigen for MPO-ANCA production by CADS and was followed by the vasculitis formation. Vasculitis did develop in a few MPO-deficient mice, though the incidence of vasculitis was much lower in MPO-deficient mice than in C57BL/6 mice.
引用
收藏
页码:381 / 387
页数:7
相关论文
共 33 条
[1]  
Aratani Y, 1999, INFECT IMMUN, V67, P1828
[2]   Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase [J].
Aratani, Y ;
Kura, F ;
Watanabe, H ;
Akagawa, H ;
Takano, Y ;
Suzuki, K ;
Maeda, N ;
Koyama, H .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (04) :1276-1279
[3]  
Bartunkova J, 1995, Bratisl Lek Listy, V96, P528
[4]   ANTIMYELOPEROXIDASE-ASSOCIATED PROLIFERATIVE GLOMERULONEPHRITIS - AN ANIMAL-MODEL [J].
BROUWER, E ;
HUITEMA, MG ;
KLOK, PA ;
DEWEERD, H ;
TERVAERT, JWC ;
WEENING, JJ ;
KALLENBERG, CGM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04) :905-914
[5]   Thyroid oxidase (THOX2) gene expression in the rat thyroid cell line FRTL-5 [J].
Dupuy, C ;
Pomerance, M ;
Ohayon, R ;
Noël-Hudson, MS ;
Déme, D ;
Chaaraoui, M ;
Francon, J ;
Virion, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 277 (02) :287-292
[6]  
Fujii A, 2000, CLIN NEPHROL, V53, P242
[7]   ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES, AUTOANTIGENS, AND SYSTEMIC VASCULITIS [J].
GROSS, WL ;
CSERNOK, E ;
HELMCHEN, U .
APMIS, 1995, 103 (02) :81-97
[8]   MOLECULAR MIMICRY IN CANDIDA-ALBICANS - ROLE OF AN INTEGRIN ANALOG IN ADHESION OF THE YEAST TO HUMAN ENDOTHELIUM [J].
GUSTAFSON, KS ;
VERCELLOTTI, GM ;
BENDEL, CM ;
HOSTETTER, MK .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) :1896-1902
[9]   A myeloperoxidase-specific assay based upon bromide-dependent chemiluminescence of luminol [J].
Haqqani, AS ;
Sandhu, JK ;
Birnboim, HC .
ANALYTICAL BIOCHEMISTRY, 1999, 273 (01) :126-132
[10]  
Harper JM, 1998, EUR J IMMUNOL, V28, P2217, DOI 10.1002/(SICI)1521-4141(199807)28:07<2217::AID-IMMU2217>3.0.CO